Fat Embolism Does Not Alter Cardiac Structure or Induce Pathological Changes in a Rat Model

Area of Science:

• Cardiovascular pathology
• Pulmonary medicine
• Trauma research

Background:

• Fat embolism (FE) is a condition where fat emboli lodge in tissues, commonly affecting the lungs after trauma.
• FE can cause significant local and systemic pathology, including lung, skin, brain, and kidney changes.
• Previous research and reports indicate extensive lung pathology but limited evidence of direct cardiac involvement in FE.

Purpose of the Study:

• To investigate the structural and molecular impact of fat embolism on the heart.
• To compare cardiac responses to fat embolism with known pulmonary pathology.
• To test the hypothesis that the heart does not exhibit structural changes similar to the lungs following fat embolism.

Main Methods:

• Utilized a previously established rat model of fat embolism (FE).
• Analyzed pulmonary and cardiac structure, histology, and gene expression at 48 hours and 10 weeks post-fat injection.
• Employed Oil Red O staining to assess fat droplet accumulation in lung, aorta, and myocardium.

Main Results:

• Despite significant lung and vasculature inflammation and structural changes up to 10 weeks post-FE, no significant alterations in cardiovascular morphometry were observed.
• No significant elevation in genetic markers for cardiac pathological hypertrophy was detected at 48 hours or 10 weeks.
• Fat droplets were present in lung and aorta tissue but not in the myocardium.

Conclusions:

• The heart demonstrates greater resistance to the inflammatory and remodeling effects of fat embolism compared to the lungs.
• Organ-specific differences in fat retention may explain the heart's resilience in fat embolism syndrome.
• Findings suggest FE primarily impacts the lungs and vasculature, with minimal direct cardiac structural consequences.